proxymetacaine has been researched along with Diabetes Mellitus, Type 2 in 1 studies
proxymetacaine: RN given refers to parent cpd; structure
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, YH | 1 |
| Kim, YS | 1 |
| Park, CH | 1 |
| Chung, IY | 1 |
| Yoo, JM | 1 |
| Kim, JG | 1 |
| Lee, BJ | 1 |
| Kang, SS | 1 |
| Cho, GJ | 1 |
| Choi, WS | 1 |
1 other study available for proxymetacaine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Protein kinase C-delta mediates neuronal apoptosis in the retinas of diabetic rats via the Akt signaling pathway.
Topics: Acetophenones; Animals; Apoptosis; Benzopyrans; Body Weight; Diabetes Mellitus, Type 2; HSP90 Heat-S | 2008 |